Xiangyu Medical Plans to Obtain Certifications for 5-6 AI Therapeutic Robot Products in 2026

Gelonghux1月14日｜Sunnyou (688626.SH) disclosed records of investor relations activities, stating that the company provides a full set of solutions empowered by brain-computer interface technology rather than single-point products. The company's related products have entered more than 600 tertiary Class A hospitals in China, with a target to cover over 1,000 such hospitals by 2026, accelerating commercialization and clinical implementation. The company has developed a comprehensive product matrix plan. Its AI physiotherapy robot series includes massage robots, shockwave robots, upper limb multi-dimensional rehabilitation training robots, transcranial magnetic stimulation robots, moxibustion robots, electromagnetic therapy robots, and radiofrequency therapy robots, with an estimated 5-6 models expected to receive certification successively by 2026. Medical exoskeleton robots and portable exoskeleton robots are projected to obtain certification by the first half of 2026. Relying on its mature rehabilitation equipment portfolio and integrating brain-computer interface technology for rapid upgrades, the core focus is on enabling software connectivity to transform passive rehabilitation devices into active ones with deep brain engagement, achieving a relatively short upgrade cycle. By June 30, 2026, 27 core products are expected to complete multi-modal and multi-paradigm upgrades; by the end of 2026, nearly 100 brain-computer interface products will be launched, with over 50 covering multi-modal and multi-paradigm capabilities.